Entity
Description
  • Value proposition

    Biocellvia evaluates the efficacy of your lead molecules from histological slides thanks to our digital technology

    Biocellvia is a french digital pathology company developing Intelligent Image Analysis solutions for pharmaceutical industry (Big Pharma, Biotechs, CRO) and academic communities involved in R&D.
    We have developed digital image analysis solutions, that enable to evaluate fully-automatically the level of efficacy of your lead molecules thanks to histological slides (in vitro, ex vivo, biopsies) in various pathologies such as:
    - Gastrointestinal (NASH, Liver fibrosis)
    - Respiratory (IPF, COPD, PAH)

    We provide image analysis as a service. Our technology evaluates your molecules with more accuracy, more reliability, more rapidity and less variability than traditional scoring methods. A full study (about 200 images) is performed in only a couple of days.

    http://biocellvia.com
    http://linkedin.com/company/biocellvia


    Oncology, Quantification, Compound validation assays, Pulmonary fibrosis, COPD, Toxicology, Numerical imaging analysis, NASH , ASTHMA , CNS, Lung cancer, Histology, CRO, Contract Research Organization, Liver disease, Asthma, NAFLD, Respiratory disease, ex vivo, in vivo, in vitro, digital pathology, IPF, clinical trial, and preclinical

  • Original language

    Biocellvia evaluates the efficacy of your lead molecules from histological slides thanks to our digital technology

    Biocellvia is a french start-up developing intelligent image analysis solutions for pharmaceutical industry, chemistry, medical and academic communities involved in R&D.
    Effectiveness and specificity are key points in our sector, that’s why Biocellvia has developed several innovative assays that evaluate, thanks to an independent observer, with a very high accuracy of the level of efficacy of active compounds for in vitro and ex vivo models in various pathologies such as:
    - Gastrointestinal (NASH, Liver fibrosis)
    - Respiratory (IPF, COPD, PAH)


    Our strong scientific expertise (CSO Pr Yvon Julé) allows us to clearly understand you and therefore provide you with custom-tailored assays. Each laboratory has its own specificities, so with Biocellvia each client has his own solutions.

    Innovation is our philosophy : all our assays are perfectly reliable, accurate, and also fully automated. With Biocellvia you can choose, our assays are available in your own laboratory by cloud solution, or you can entrust studies. Biocellvia saves your time and your money !

    You need a very special assay? We're ready to take up the challenge !

Corporate interactions BETA
Corporate TypeTweets Articles
SATT Sud-Est
SATT Sud-Est
Research, National and local authorities, Research Services
SATT Sud-Est
Research, National and local authorities, Research Services
Other

3 Feb 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

9 Feb 2024


thecamp
thecamp
Startup accelerator & VC, Business Consulting and Services
thecamp
Startup accelerator & VC, Business Consulting and Services
Capitalistic
Not partnership
Not event

13 Mar 2019


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Not capitalistic
Partnership
Event

18 Jun 2018


La French Tech Aix-Marseille Région Sud
La French Tech Aix-Marseille Région Sud
French Tech, Software Development
La French Tech Aix-Marseille Région Sud
French Tech, Software Development
Other

8 Mar 2019

21 Nov 2023



Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

30 Nov 2021


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

9 Feb 2024


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

30 Sep 2021


Similar entities
Loading...
Loading...
Social network dynamics